About
Machine Learning for Therapeutic Protein Design
Areas of Focus
Categories
Biologics & BiopharmaceuticalAI FocusedBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
247
By Phase
PHASE1: 3
By Status
RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06920693Lead Sponsor
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants
PHASE1Recruiting
40 participants
Started: Mar 27, 2025 · Completed: Jun 30, 2026
NCT07116889Lead Sponsor
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
PHASE1Recruiting
156 participants
Started: Dec 12, 2023 · Completed: May 31, 2027
NCT07050511Lead Sponsor
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants
PHASE1Completed
51 participants
Started: Jul 18, 2023 · Completed: Nov 22, 2024
Locations (1)
Headquarters
Somerville, MA, United States
Map
Loading map...